OBJECTIVE: To evaluate associations between use of seven progestogens and incident
acute venous thromboembolism (VTE) among women of reproductive age. METHODS: This …

Introduction The increased risk of venous thromboembolism associated with the use of
hormonal contraception is well recognized, but evidence regarding hormonal contraception …

Objective: To review the incidence of venous thromboembolism (VTE) in association with
combined cyproterone acetate and ethinylestradiol (CPA/EE) use, compared to the …

OBJECTIVE: To estimate the absolute and relative risk of venous thromboembolism (VTE)
among women who initiate depot medroxyprogesterone acetate (DMPA) immediately …

Background Women with medical conditions associated with increased risk for thrombosis
generally should not use estrogen-containing contraceptives; however, less is known about …

Background: Current use of menopausal hormone therapy (HT) increases the risk of venous
thromboembolism (VTE) and the formulations used may affect risk. Methods: A total of 1 058 …

A matched case-control study was undertaken in 10 centers in Germany and the United
Kingdom to explore the association of current use of major combination oral contraceptives …

Background Venous thromboses are well‐established complications of hormonal therapy.
Thrombosis risk is seen with both hormonal contraceptive agents and with hormone …

Despite a decrease in the use of postmenopausal hormone therapy (HT) over the last
decade, many women are still prescribed this treatment, as it remains the most effective …

Purpose The data on the association between hormone replacement therapy and the
increased risk of venous thromboembolism (VTE) in postmenopausal women are conflicting …